Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
October 8, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - MRNA
11:30am, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna's spending cuts, pipeline shakeup leave doubts about a rebound, analysts say
11:15am, Friday, 13'th Sep 2024
Moderna's cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some products and qu
Moderna Inc May Have Violated Securities Laws And Affected Stockholders Are Urged To Contact The Schall Law Firm About A Suit
11:00am, Friday, 13'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
09:42am, Friday, 13'th Sep 2024
MRNA RECEIVES SIGNAL AT 10:21 AND RISES THROUGHOUT THE DAY
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
09:21am, Friday, 13'th Sep 2024
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of low sales projections and poor vac
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
09:09am, Friday, 13'th Sep 2024
Analysts come up with their key catalyst watch list that can help Moderna shares get out of the rut.
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
07:30am, Friday, 13'th Sep 2024
Moderna may have a number of new product launches ahead. Pfizer is a big pharma stock that's poised for a big comeback.
Investors who Lost Money on Moderna, Inc. (MRNA) Should Contact Levi & Korsinsky About Pending Class Action - MRNA
07:15am, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
MRNA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Moderna, Inc. to Contact the Firm Today!
07:00am, Friday, 13'th Sep 2024
NEW YORK CITY, NY / ACCESSWIRE / September 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Modern
MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:45am, Friday, 13'th Sep 2024
NEW YORK , Sept. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
S&P 500 Gains and Losses Today: Moderna Stock Plunges as Firm Plans R&D Cuts
05:05pm, Thursday, 12'th Sep 2024
Major U.S. equities indexes headed higher after the latest Producer Price Index (PPI) report showed a cooldown in wholesale inflation in August, the latest data point that could tip the scales toward
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact Levi & Korsinsky
05:00pm, Thursday, 12'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
3-Stock Lunch: Moderna, Delta Air Lines & Signet Jewelers
03:20pm, Thursday, 12'th Sep 2024
Eva Ados, ERShares chief investment strategist, joins 'Power Lunch' to discuss stock plays for three stocks.
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna Stock Plummets on Cost-Cutting Measures
11:02am, Thursday, 12'th Sep 2024
Shares of Moderna Inc (NASDAQ:MRNA) are plummeting today, after the biotech giant announced it was slashing its research budget by about 20%.
